138 related articles for article (PubMed ID: 25875128)
1. Differential adjuvant activities of TLR7 and TLR9 agonists inversely correlate with nitric oxide and PGE2 production.
Lee J; Martinez N; West K; Kornfeld H
PLoS One; 2015; 10(4):e0123165. PubMed ID: 25875128
[TBL] [Abstract][Full Text] [Related]
2. Robust interferon-α and IL-12 responses by dendritic cells are related to efficient CD4+ T-cell recovery in HIV patients on ART.
Tan DB; Yong YK; Lim A; Tan HY; Kamarulzaman A; French M; Price P
Clin Immunol; 2011 May; 139(2):115-21. PubMed ID: 21429806
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse.
Lee AS; Ghoreishi M; Cheng WK; Chang TY; Zhang YQ; Dutz JP
Diabetologia; 2011 Jun; 54(6):1407-16. PubMed ID: 21340621
[TBL] [Abstract][Full Text] [Related]
4. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
5. Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.
Moreno Ayala MA; Gottardo MF; Gori MS; Nicola Candia AJ; Caruso C; De Laurentiis A; Imsen M; Klein S; Bal de Kier Joffé E; Salamone G; Castro MG; Seilicovich A; Candolfi M
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1713-1732. PubMed ID: 28432455
[TBL] [Abstract][Full Text] [Related]
6. Role of marginal zone B lymphocytes in invariant NKT cell activation.
Bialecki E; Paget C; Fontaine J; Capron M; Trottein F; Faveeuw C
J Immunol; 2009 May; 182(10):6105-13. PubMed ID: 19414762
[TBL] [Abstract][Full Text] [Related]
7. Accessory cell-derived IL-12 and prostaglandin E2 determine the IFN-gamma level of activated human CD4+ T cells.
Hilkens CM; Snijders A; Vermeulen H; van der Meide PH; Wierenga EA; Kapsenberg ML
J Immunol; 1996 Mar; 156(5):1722-27. PubMed ID: 8596019
[TBL] [Abstract][Full Text] [Related]
8. Positive T cell co-stimulation by TLR7/8 ligands is dependent on the cellular environment.
Richardt-Pargmann D; Wechsler M; Krieg AM; Vollmer J; Jurk M
Immunobiology; 2011; 216(1-2):12-23. PubMed ID: 20542588
[TBL] [Abstract][Full Text] [Related]
9. pDC Activation by TLR7/8 Ligand CL097 Compared to TLR7 Ligand IMQ or TLR9 Ligand CpG.
Wu J; Li S; Li T; Lv X; Zhang M; Zang G; Qi C; Liu YJ; Xu L; Chen J
J Immunol Res; 2019; 2019():1749803. PubMed ID: 31093508
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2-dependent IL-23 production in aged murine dendritic cells.
Myer RG; El Mezayen R; High KP
Exp Gerontol; 2010 Nov; 45(11):834-41. PubMed ID: 20600778
[TBL] [Abstract][Full Text] [Related]
11. Comparison of human B cell activation by TLR7 and TLR9 agonists.
Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
[TBL] [Abstract][Full Text] [Related]
12. Resting but not CpG stimulated keratinocytes suppress autologous T-helper cell proliferation--importance of PGE2 and T regulatory function.
Kopfnagel V; Werfel T; Wittmann M
Exp Dermatol; 2011 May; 20(5):394-400. PubMed ID: 21426407
[TBL] [Abstract][Full Text] [Related]
13. Human dendritic cells stimulated via TLR7 and/or TLR8 induce the sequential production of Il-10, IFN-gamma, and IL-17A by naive CD4+ T cells.
Lombardi V; Van Overtvelt L; Horiot S; Moingeon P
J Immunol; 2009 Mar; 182(6):3372-9. PubMed ID: 19265114
[TBL] [Abstract][Full Text] [Related]
14. Switching from a restricted to an effective CD4 T cell response by activating CD8+ murine dendritic cells with a Toll-like receptor 9 ligand.
Rizzitelli A; Vremec D; Villadangos JA; Mavaddat N; Wright MD; Shortman K
Eur J Immunol; 2005 Nov; 35(11):3209-20. PubMed ID: 16224811
[TBL] [Abstract][Full Text] [Related]
15. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein.
Fujii S; Shimizu K; Smith C; Bonifaz L; Steinman RM
J Exp Med; 2003 Jul; 198(2):267-79. PubMed ID: 12874260
[TBL] [Abstract][Full Text] [Related]
16. The adjuvant effect of TLR agonists on CD4(+) effector T cells is under the indirect control of regulatory T cells.
Olivier A; Sainz-Perez A; Dong H; Sparwasser T; Majlessi L; Leclerc C
Eur J Immunol; 2011 Aug; 41(8):2303-13. PubMed ID: 21538349
[TBL] [Abstract][Full Text] [Related]
17. [Resiquimod (R848) has more stronger immune adjuvantivity than other tested TLR agonists].
Shen Y; Zeng M; Qiu F; Tang H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 May; 33(5):591-596. PubMed ID: 28502294
[TBL] [Abstract][Full Text] [Related]
18. Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen.
Lee YR; Lee YH; Im SA; Yang IH; Ahn GW; Kim K; Lee CK
Arch Pharm Res; 2010 Nov; 33(11):1859-66. PubMed ID: 21116790
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell inhibition of T-helper 17 cell- differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor.
Duffy MM; Pindjakova J; Hanley SA; McCarthy C; Weidhofer GA; Sweeney EM; English K; Shaw G; Murphy JM; Barry FP; Mahon BP; Belton O; Ceredig R; Griffin MD
Eur J Immunol; 2011 Oct; 41(10):2840-51. PubMed ID: 21710489
[TBL] [Abstract][Full Text] [Related]
20. Splenic stroma-educated regulatory dendritic cells induce apoptosis of activated CD4 T cells via Fas ligand-enhanced IFN-γ and nitric oxide.
Xu X; Yi H; Guo Z; Qian C; Xia S; Yao Y; Cao X
J Immunol; 2012 Feb; 188(3):1168-77. PubMed ID: 22205032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
